Search

Search Constraints

You searched for: Author/Creator Rao, S

Search Results

6. 646PEGFR amplification (amp) and survival in the REAL-3 trial. (23rd October 2018)

8. 874PTreatment-free interval (TFI) following discontinuation of first-line nivolumab plus ipilimumab (N+I) or sunitinib (S) in patients (Pts) with advanced renal cell carcinoma (aRCC): CheckMate 214 analysis. (23rd October 2018)